| Registos Bibliográficos associados ao registo de autoridade |
|
Etiqueta de registo: 00230nam 2200025 450
001 1377763
003 http://id.bnportugal.gov.pt/bib/catbnp/1377763
100 ## $a20060808d2004 k y0pory0103 ba
101 0# $apor$deng
102 ## $aPT
105 ## $aa m 001yy
106 ## $ar
200 1# $aRegimes terapêuticos para a úlcera péptica e para a erradicação de Helicobacter pylori
em Portugal$bTexto policopiado]$econtributo farmacoepidemiológico$fAna Paula Martins $gorient. José Cabrita, António de Sousa Guerreiro
210 #9 $aLisboa$c[s.n.],$d2004
215 ## $a[293] p.$cil.$d30 cm$ecurriculum vitae (17 f.)
320 ## $aContém bibliografia
328 #0 $bTese dout.$cFarmácia, (Farmácia Clínica)$eFac. de Farmácia, Univ. de Lisboa$d2004
606 ## $aÚlcera péptica$xTerapêuticas$x[Teses]$2SIPOR$31282087
675 ## $a616.33-008.8(043)$vBN$zpor$31264136
675 ## $a615.24.03(043)$vBN$zpor$31264137
700 #1 $aMartins,$bAna Paula$f1965-$31251573
702 #1 $aCabrita,$bJosé,$f1954-$4727$3193980
702 #1 $aGuerreiro,$b António de Sousa$4727$31251574
801 #0 $aPT$bBN$gRPC
966 ## $lBN$mFGMON$sS.A. 115161 V.$x1
Etiqueta de registo: 00000nam 2200025 450
001 2112219
003 http://id.bnportugal.gov.pt/bib/catbnp/2112219
100 ## $a20221012d2022 k y0pory01030103ba
101 0# $aeng$dpor
102 ## $aPT
105 ## $aa m 000yy
106 ## $ar
200 1# $aPatient safety$ecardio and cerebrovascular risk of major adverse events following exposure to potentially
inappropriate medications$fJoão Pedro Teixeira Aguiar$gorient. Filipa Alves Costa, Ana Paula Martins, Hubert G. M. Leufkens
210 #9 $aLisboa$c[s.n.],$d2022
215 ## $aXXVIII, 211, [10] p.$cil.$d30 cm
328 #1 $aTese dout. Farmácia (Farmacoepidemiologia), Fac. de Farmácia, Univ. de Lisboa, 2022
675 ## $a615(043)$vBN$zpor$31318077
700 #1 $aAguiar,$bJoão Pedro Teixeira$31861021
702 #1 $aCosta,$bFilipa Alves$4727$31861022
702 #1 $aLeufkens,$bHubert G. M.$4727$31733408
702 #1 $aMartins,$bAna Paula$f1965-$4727$31251573
801 #0 $aPT$bBN$gRPC
856 40 $2Cópia digital disponível no Repositório Universidade de Lisboa$uhttp://hdl.handle.net/10451/54885
966 ## $lBN$mFGMON$sS.A. 183539 V.$x1
971 ## $ccsilva$d20221012
972 ## $e0$z0$d20230220$viquintas
973 ## $cmlsousa$d20230216
Etiqueta de registo: 00000nam 2200025 450
001 2024590
003 http://id.bnportugal.gov.pt/bib/catbnp/2024590
021 ## $aPT$b445785/18
100 ## $a20190625d2019 m y0pory01030103ba
101 0# $apor
102 ## $aPT
105 ## $aa z 000yd
106 ## $ar
200 1# $aCarlos Silveira$ftextos Ana Paula Martins... [et al.]
205 ## $a1ª ed
210 #9 $a[S.l.]$cOrdem dos Farmacêuticos,$d2019
215 ## $a139, [2] p.$cil.$d26 cm
225 2# $aFarmacêuticos$v1
675 ## $a929Silveira, Carlos$vBN$zpor$31757258
675 ## $a615.12(469)"196/200"$vBN$zpor$31757262
675 ## $a614.2(469)"196/200"$vBN$zpor$31757263
675 ## $a821.134.3-94"19/20"$vBN$zpor$31039422
701 #1 $aMartins,$bAna Paula$f1965-$4070$31251573
801 #0 $aPT$bBN$gRPC
856 41 $uhttp://rnod.bnportugal.gov.pt/ImagesBN/winlibimg.aspx?skey=&doc=2024590&img=127397&save=true
900 ## $aBIBNAC$d20190722
966 ## $lBN$mFGMON$sH.G. 78010 V.$x1
966 ## $lBN$mFGMON$sH.G. 78010 V.-D$x1
Etiqueta de registo: 00230nam 2200025 450
001 1739792
003 http://id.bnportugal.gov.pt/bib/catbnp/1739792
100 ## $a20100309d2008 k y0pory0103 ba
101 0# $apor$deng
102 ## $aPT
105 ## $aa m 000yy
106 ## $ar
200 1# $aVigilância activa de eventos após vacinação$bTexto policopiado]$fLuís Correia Pinheiro$gorient. Ana Paula M. de Almeida Martins S. Correia
210 #9 $aLisboa$c[s.n.],$d2008
215 ## $a[104] f. $cil.$d30 cm
320 ## $aBibliografia, f. 82-88
328 ## $bTese mestr.$cEpidemiologia$eFac. de Ciências Médicas de Lisboa, Univ. Nova de Lisboa$d2008
675 ## $a614.47(043)$vBN$zpor$31388156
675 ## $a616-083(043)$vBN$zpor$3556472
700 #1 $aPinheiro,$bLuís Correia$31413134
702 #1 $aMartins,$bAna Paula$f1965-$4727$31251573
712 02 $aUniversidade Nova de Lisboa.$bFaculdade de Ciências Médicas$4295$320135
801 #0 $aPT$bBN$gRPC
966 ## $lBN$mFGMON$sS.A. 131220 V.$x1
Etiqueta de registo: 00000nam 2200025 450
001 2005034
003 http://id.bnportugal.gov.pt/bib/catbnp/2005034
100 ## $a20181112d2018 k y0pory01030103ba
101 0# $aeng$dpor
102 ## $aPT
105 ## $ay m 000yy
106 ## $ar
200 1# $aIntensive monitoring in Portugal$e a pharmacy-based model to assess medicines in real-life conditions$e the example of new glucose lowering drugs$fCarla de Matos Torre$gorient. Ana Paula Martins, Hubert G. M. Leufkens
210 #9 $aLisboa$c[s.n.],$d2018
215 ## $a278 p.$d30 cm$ecurriculum vitae (8 p.)
328 #1 $aTese dout. Farmácia (Farmacoepidemiologia), Faculdade de Farmácia, Univ. Lisboa, 2018
675 ## $a615.015(469)(043)$vBN$zpor$31317391
675 ## $a616.379-008.6(043)$vBN$zpor$31225752
700 #1 $aTorres,$bCarla de Matos$31733407
702 #1 $aMartins,$bAna Paula$f1965-$4727$31251573
702 #1 $aLeufkens,$bHubert G. M.$4727$31733408
801 #0 $aPT$bBN$gRPC
966 ## $lBN$mFGMON$sS.A. 170357 V.$x1
Etiqueta de registo: 00000nam 2200025 450
001 2013028
003 http://id.bnportugal.gov.pt/bib/catbnp/2013028
100 ## $a20190130d2018 k y0pory01030103ba
101 0# $aeng$dpor
102 ## $aPT
105 ## $aa m 000yy
106 ## $ar
200 1# $aStarting material$econcept and impact on pharmaceutical regulations$fAna Paula Moreira da Costa Folhadeira Simões$gorient. José Manuel Sousa Lobo, Ana Paula Martins
210 #9 $aPorto$c[s.n.],$d2018
215 ## $aXI, 198 f.$cil.$d30 cm
328 #1 $aTese dout. Ciências Farmacêuticas (Tecnologia Farmacêutica), Fac. de Farmácia, Univ.
do Porto, 2018
675 ## $a615.1(043)$vBN$zpor$31468511
675 ## $a614.27(043)$vBN$zpor$31358953
675 ## $a174(043)$vBN$zpor$3298061
700 #1 $93$aAna Paula Costa$31742411
702 #1 $aLobo,$bJ. M. Sousa,$f1951-$4727$31398767
702 #1 $aMartins,$bAna Paula$f1965-$4727$31251573
801 #0 $aPT$bBN$gRPC
966 ## $lBN$mFGMON$sS.A. 171078 V.$x1
Etiqueta de registo: 00000nam 2200025 450
001 2020464
003 http://id.bnportugal.gov.pt/bib/catbnp/2020464
100 ## $a20190424d2018 k y0pory01030103ba
101 0# $aeng$dpor
102 ## $aPT
105 ## $aa m 000yy
106 ## $ar
200 1# $aContribution of medical affairs to an efficient management in the pharmaceutical industry$dContribuição dos assuntos médicos para uma gestão eficiente na indústria farmacêutica$fJosé Augusto Aleixo Dias$gorient. José Manuel Calheiros, Luís Almeida, Ana Paula Mecheiro de Almeida Martins
Silvestre Correia$zpor
210 #9 $aAveiro$c[s.n.],$d2018
215 ## $aXIII, 211 p.$cil.$d30 cm
328 #1 $aTese dout. Ciências e Tecnologias da Saúde, Univ. Aveiro, 2018
510 1# $aContribuição dos assuntos médicos para uma gestão eficiente na indústria farmacêutica$zpor
675 ## $a615.012(043)$vBN$zpor$31042966
675 ## $a615.1(043)$vBN$zpor$31468511
675 ## $a616.12(043)$vBN$zpor$31324322
700 #1 $aDias,$bJosé Augusto Aleixo,$f1952-$3116462
702 #1 $aCalheiros,$bJosé Manuel,$f1947-$4727$3273259
702 #1 $94$aAlmeida,$bLuís$4727$31485421
702 #1 $aMartins,$bAna Paula$f1965-$4727$31251573
801 #0 $aPT$bBN$gRPC
966 ## $lBN$mFGMON$sS.A. 172389 V.$x1
Etiqueta de registo: 00000nam 2200025 450
001 2055562
003 http://id.bnportugal.gov.pt/bib/catbnp/2055562
010 ## $a978-989-96318-6-1
021 ## $aPT$b464931/19
100 ## $a20200925g20199999m y0pory01030103ba
101 0# $apor
102 ## $aPT
105 ## $aa z 000yy
106 ## $ar
200 1# $aCrónicas da farmácia$fAntónio Hipólito de Aguiar$gpref. Ana Paula Martins$gcolab. Clara Carneiro... [et al.]
205 ## $a1ª ed
210 #9 $aLisboa$cHollyfar - Marcas e Comunicação,$d2019-
215 ## $av.$cil.$d21 cm
225 2# $aFarmácia distribuição
675 ## $a615.1"2011/2019"(046)$vBN$zpor$31792567
675 ## $a821.134.3-92"20"$vBN$zpor$31049730
700 #1 $aAguiar,$bAntónio Hipólito de,$f1969-$3950510
702 #1 $aMartins,$bAna Paula$f1965-$4080$31251573
702 #1 $aCarneiro,$bClara$4205$31373123
801 #0 $aPT$bBN$gRPC
856 41 $uhttp://rnod.bnportugal.gov.pt/ImagesBN/winlibimg.aspx?skey=&doc=2055562&img=143466&save=true
900 ## $aBIBNAC$d20201015
966 ## $b001$dV 1$lBN$mFGMON$sC.G. 23342 V.$x1
966 ## $b001$dV. 1$lBN$mFGMON$sC.G. 23342 V.-D$x1
Etiqueta de registo: 00000nam 2200025 450
001 2061536
003 http://id.bnportugal.gov.pt/bib/catbnp/2061536
100 ## $a20201214d2020 k y0pory01030103ba
101 0# $apor$deng
102 ## $aPT
105 ## $aa m 000yy
106 ## $ar
200 1# $aAssociação entre a terapêutica com cetuximab e bevacizumab e outcomes em doentes com
cancro colorrectal metastizado$e um estudo de efectividade comparativa em oncologia$fRui Pedro Pinheiro Gonçalves Marques$gorient. Ana Paula Mecheiro de Almeida Martins Silvestre Correia, António Augusto Figuieredo
Guterres Quintela
210 #9 $aLisboa$c[s.n.],$d2020
215 ## $a288 p.$cil.$d30 cm$ecurriculum vitae ([1] f.)
328 #1 $aTese dout. Farmácia (Farmacoepidemiologia), Faculdade de Farmácia, Univ. de Lisboa,
2020
675 ## $a615.27(043)$vBN$zpor$31246492
675 ## $a615.03(043)$vBN$zpor$3527623
675 ## $a616.348/.35-006.6(043)$vBN$zpor$31644653
700 #1 $aMarques,$bRui Pedro Pinheiro Gonçalves$31798155
702 #1 $aMartins,$bAna Paula$f1965-$4727$31251573
702 #1 $aQuintela,$bAntónio Augusto Figuieredo Guterres$4727$31798156
801 #0 $aPT$bBN$gRPC
856 40 $2Cópia digital disponível no Repositório Universidade de Lisboa$uhttp://hdl.handle.net/10451/45280
966 ## $lBN$mFGMON$sS.A. 176082 V.$x1
Etiqueta de registo: 00254nam 2200025 450
001 2092608
003 http://id.bnportugal.gov.pt/bib/catbnp/2092608
010 ## $a978-989-53457-2-4
021 ## $aPT$b497663/22
100 ## $a20220215d2022 k y0pory01030103ba
101 0# $apor
102 ## $aPT
105 ## $aa z 001yy
106 ## $ar
200 1# $aSaúde em Portugal$epensar o futuro$fAna Paula Martins... [et al.]$gcoord. Adalberto Campos Fernandes$gpref. Luís Portela
210 #9 $aCoimbra$cEditora d'Ideias,$d2022
215 ## $a299 p.$cil.$d23 cm
675 ## $a614.2(469)"20"$vBN$zpor$31462213
675 ## $a614.39(469)"20"$vBN$zpor$31494231
701 #1 $aMartins,$bAna Paula$f1965-$4070$31251573
702 #1 $aFernandes,$bAdalberto Campos,$f1958-$4340$3817577
702 #1 $aPortela,$bLuís,$f1951-$4080$3263277
801 #0 $aPT$bBN$gRPC
856 41 $uhttp://rnod.bnportugal.gov.pt/ImagesBN/winlibimg.aspx?skey=&doc=2092608&img=166938&save=true
900 ## $aBIBNAC$d20220809
966 ## $lBN$mFGMON$sS.A. 181312 V.$x1
966 ## $lBN$mFGMON$sS.A. 181312 V.-D$x1
971 ## $cssilva$d20220630
972 ## $e0$z0$d20220809$vasantos
973 ## $cmlsousa$d20220802
Etiqueta de registo: 00254nam 2200025 450
001 2114049
003 http://id.bnportugal.gov.pt/bib/catbnp/2114049
100 ## $a20221103d2021 k y0pory01030103ba
101 0# $aeng$dpor
102 ## $aPT
105 ## $aa m 000yy
106 ## $ar
200 1# $aPatterns of polypharmacy and potential overtreatment in elderly people with type 2
diabetes mellitus using real-world data$fLabib Al-Musawe$gorient. Carla de Matos Torre, Ana Paula Martins, Helder Mota-Filipe
210 #9 $aLisboa$c[s.n.],$d2021
215 ## $a[6], 230, [2] f.$cil.$d30 cm
328 #1 $aTese dout. Farmácia (Farmacoepidemiologia), Fac. de Farmácia, Univ. de Lisboa, 2021
675 ## $a615.24(043)$vBN$zpor$31273045
675 ## $a616.379-008.6-085(043)$vBN$zpor$31222637
700 #1 $aAl-Musawe,$bLabib$31862765
702 #1 $aTorre,$bCarla de Matos$4727$31862769
702 #1 $aMartins,$bAna Paula$f1965-$4727$31251573
702 #1 $aFilipe,$bHelder Dias Mota,$f1965-$4727$3158907
801 #0 $aPT$bBN$gRPC
856 40 $2Cópia digital disponível no Repositório Universidade de Lisboa$uhttp://hdl.handle.net/10451/48528
966 ## $lBN$mFGMON$sS.A. 183686 V.$x1
971 ## $cfatima$d20221103
972 ## $e0$z0$d20230317$vasantos
973 ## $cigoulao$d20230308
Etiqueta de registo: 00254nam 2200025 450
001 2113955
003 http://id.bnportugal.gov.pt/bib/catbnp/2113955
100 ## $a20221102d2020 k y0pory01030103ba
101 0# $aeng$dpor
102 ## $aPT
105 ## $aa m 000yy
106 ## $ar
200 1# $aAdvanced therapy medicinal products$enew strategies for clinical applications of cell and gene therapy$fMarta Alexandra Bogalho Rodrigues de Carvalho$gorient. Ana Paula Mecheiro de Almeida Martins Silvestre Correia, Bruno Miguel Nogueira
Sepodes
210 #9 $aLisboa$c[s.n.],$d2020
215 ## $a240 p.$cil.$d30 cm
328 #1 $aTese dout. Farmácia (Farmacologia e Farmacoterapia), Fac. de Farmácia, Univ. de Lisboa,
2020
675 ## $a615(043)$vBN$zpor$31318077
700 #1 $aCarvalho,$bMarta Alexandra Bogalho Rodrigues de$31862931
702 #1 $aMartins,$bAna Paula$f1965-$4727$31251573
702 #1 $aSepodes,$bBruno Miguel Nogueira$4727$31567564
801 #0 $aPT$bBN$gRPC
966 ## $lBN$mFGMON$sS.A. 183172 V.$x1
971 ## $cfatima$d20221102
972 ## $e0$z0$d20230113$viquintas
973 ## $cmlsousa$d20230106
|
|
|
